Stock AnalizNational Healthcare Properties, Inc. NHP
Real Estate Investment Trusts · data as of November 13, 2026
National Healthcare Properties, Inc. (NHP) is a real estate company listed in the US with a market value of about $1.1B. In the twelve months to September 30, 2026 it had revenue of $361M and net income of -$24M, a net margin of -6.6%.
Its overall Stock Analiz score is 0.6 out of 5 (weak). The strongest part is future growth (1/5); the weakest is value (0/5).
Key numbers: a price to free cash flow of 43.9, 5-year revenue growth of -2% a year, a 5-year average ROIC of -2%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 69% below the current price.
Score: 0.6 / 5
Checks passed
- Profit margin improving
- Positive free cash flow
- Stock-based pay below 5% of revenue
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- 3-year free cash flow growth above 10% a year
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $361M | $342M | $354M | $346M | $336M | $329M | $382M | $375M | $362M | $311M | $303M |
| Net income | -$24M | -$71M | -$203M | -$86M | -$93M | -$93M | -$79M | -$88M | -$53M | -$43M | -$21M |
| Free cash flow | $25M | -$22M | -$102M | -$773000 | $302000 | $20M | $20M | $31M | $41M | $56M | $71M |
| EPS (diluted) | $-1.08 | $-2.51 | $-7.19 | $-3.04 | $-3.30 | $-3.28 | $-2.96 | $-3.52 | $-2.24 | $-1.88 | $-0.96 |
| Net margin | -6.6% | -20.8% | -57.5% | -24.9% | -27.8% | -28.2% | -20.6% | -23.5% | -14.6% | -13.7% | -6.9% |
| ROIC | — | 0.2% | -5.3% | -0.2% | -1.2% | -1.4% | -0.7% | -1.1% | -0.2% | -0.7% | -0.2% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 7 analysts is $19.57, 30% above the current price; targets range from $17.00 to $24.00; the consensus rating is “Buy”; expected EPS is $0.93 for the fiscal year ending December 31, 2026.
Frequently asked questions
Is National Healthcare Properties stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 69% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does National Healthcare Properties pay a dividend?
Yes. The dividend yield is about 2.00%, and it has paid dividends for 5 years in our data.
Is National Healthcare Properties a good stock to buy?
We do not give buy or sell advice. National Healthcare Properties scores 0.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.